Anthropometric Changes in Patients with Pancreatic Cancer Undergoing Preoperative Therapy and Pancreatoduodenectomy

[1]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[2]  Jeffrey E. Lee,et al.  Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma , 2017, JAMA surgery.

[3]  K. Roggin,et al.  Can Comprehensive Imaging Analysis with Analytic Morphomics and Geriatric Assessment Predict Serious Complications in Patients Undergoing Pancreatic Surgery? , 2017, Journal of Gastrointestinal Surgery.

[4]  Edward Stefanowicz,et al.  Morphometric Predictors of Morbidity after Pancreatectomy , 2016, The American surgeon.

[5]  J. Hussey,et al.  The ability of prehabilitation to influence postoperative outcome after intra-abdominal operation: A systematic review and meta-analysis. , 2016, Surgery.

[6]  J. Batsis,et al.  Sarcopenia and sarcopenic obesity: do they predict inferior oncologic outcomes after gastrointestinal cancer surgery? , 2016, Perioperative Medicine.

[7]  Jeffrey E. Lee,et al.  Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma , 2016, Cancer.

[8]  M. Katz,et al.  Poster 68 Feasibility of a Prehabilitation Program for Patients with Potentially Resectable Pancreatic Cancer: Pilot Study , 2016, PM & R : the journal of injury, function, and rehabilitation.

[9]  H. Lenz,et al.  Molecular Pathways: Cachexia Signaling—A Targeted Approach to Cancer Treatment , 2016, Clinical Cancer Research.

[10]  H. Kume,et al.  Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for Metastatic Urothelial Carcinoma. , 2016, Clinical genitourinary cancer.

[11]  M. Makary,et al.  Inclusion of Sarcopenia Outperforms the Modified Frailty Index in Predicting 1-Year Mortality among 1,326 Patients Undergoing Gastrointestinal Surgery for a Malignant Indication. , 2016, Journal of the American College of Surgeons.

[12]  R. Beets-Tan,et al.  Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients , 2016, Journal of cachexia, sarcopenia and muscle.

[13]  M. G. Doherty,et al.  Sarcopenia and survival in patients undergoing pancreatic resection. , 2016, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[14]  M. Braga,et al.  Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery , 2016, The British journal of surgery.

[15]  D. Coit,et al.  Patterns and Predictors of Weight Loss After Gastrectomy for Cancer , 2016, Annals of Surgical Oncology.

[16]  J. Ijzermans,et al.  Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies , 2015, The British journal of surgery.

[17]  Y. Bang,et al.  Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index , 2015, PloS one.

[18]  K. Kichikawa,et al.  Prognostic Significance of Muscle Attenuation in Pancreatic Cancer Patients Treated with Neoadjuvant Chemoradiotherapy , 2015, World Journal of Surgery.

[19]  K. Roggin,et al.  Radiographic Sarcopenia and Self-reported Exhaustion Independently Predict NSQIP Serious Complications After Pancreaticoduodenectomy in Older Adults , 2015, Annals of Surgical Oncology.

[20]  Jeffrey E. Lee,et al.  Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer , 2015, Annals of Surgical Oncology.

[21]  M. Ohmuraya,et al.  Impact of Postoperative Weight Loss on Survival After Resection for Pancreatic Cancer. , 2015, JPEN. Journal of parenteral and enteral nutrition.

[22]  M. Mizumoto,et al.  Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. , 2015, Surgery.

[23]  Benjamin E. Johnson,et al.  Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma , 2015, Journal of surgical oncology.

[24]  G. Spolverato,et al.  Impact Total Psoas Volume on Short- and Long-Term Outcomes in Patients Undergoing Curative Resection for Pancreatic Adenocarcinoma: a New Tool to Assess Sarcopenia , 2015, Journal of Gastrointestinal Surgery.

[25]  J. Chabot,et al.  Pancreatic cancer surgery and nutrition management: a review of the current literature. , 2015, Hepatobiliary surgery and nutrition.

[26]  Julien Taieb,et al.  Sarcopenia Is Linked to Treatment Toxicity in Patients With Metastatic Colorectal Cancer , 2014, Nutrition and cancer.

[27]  R. Wolff,et al.  Does IGFR1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer? , 2014, Journal of cachexia, sarcopenia and muscle.

[28]  V. Goh,et al.  Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer , 2014, European Radiology.

[29]  S. Sonnad,et al.  Psoas:lumbar vertebra index: central sarcopenia independently predicts morbidity in elderly trauma patients , 2013, European Journal of Trauma and Emergency Surgery.

[30]  L. Mccargar,et al.  Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  A. Loundou,et al.  Prognostic impact of weight loss in 1-year survivors after transthoracic esophagectomy for cancer. , 2012, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[32]  Kevin He,et al.  Analytic Morphomics, Core Muscle Size, and Surgical Outcomes , 2012, Annals of surgery.

[33]  Jeffrey E. Lee,et al.  Retroperitoneal dissection in patients with borderline resectable pancreatic cancer: operative principles and techniques. , 2012, Journal of the American College of Surgeons.

[34]  Michael A. Choti,et al.  Impact of Sarcopenia on Outcomes Following Resection of Pancreatic Adenocarcinoma , 2012, Journal of Gastrointestinal Surgery.

[35]  Jeffrey E. Lee,et al.  Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy. , 2012, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[36]  B. Leiby,et al.  A progressive postresection walking program significantly improves fatigue and health-related quality of life in pancreas and periampullary cancer patients. , 2012, Journal of the American College of Surgeons.

[37]  A. Aslani,et al.  Long‐term changes in body composition after pancreaticoduodenectomy , 2012, ANZ journal of surgery.

[38]  M. Kook,et al.  Changing pattern of postoperative body weight and its association with recurrence and survival after curative resection for gastric cancer. , 2012, Hepato-gastroenterology.

[39]  D. Hwang,et al.  Practical usefulness of minor grooves of the hepatic surface for liver resection. , 2012, Hepato-gastroenterology.

[40]  Jeffrey E. Lee,et al.  Defined Clinical Classifications Are Associated with Outcome of Patients with Anatomically Resectable Pancreatic Adenocarcinoma Treated with Neoadjuvant Therapy , 2012, Annals of Surgical Oncology.

[41]  Paula Ravasco,et al.  Definition and classification of cancer cachexia: an international consensus. , 2011, The Lancet. Oncology.

[42]  Sandrine Andrieu,et al.  Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. , 2011, Journal of the American Medical Directors Association.

[43]  J. Baeyens,et al.  Sarcopenia: European consensus on definition and diagnosis , 2010, Age and ageing.

[44]  G. Biolo,et al.  Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". , 2010, Clinical nutrition.

[45]  Tony Reiman,et al.  A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. , 2008, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[46]  Douglas B. Evans,et al.  Development of an Integrated Biospecimen Bank and Multidisciplinary Clinical Database For Pancreatic Cancer , 2008, Annals of Surgical Oncology.

[47]  Jeffrey E. Lee,et al.  Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy , 2006, Annals of Surgical Oncology.

[48]  Jin‐Young Jang,et al.  Comparison of the Functional Outcome after Pylorus-preservingPancreatoduodenectomy: Pancreatogastrostomy and Pancreatojejunostomy , 2002, World Journal of Surgery.

[49]  A. Norman,et al.  Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? , 1998, European journal of cancer.

[50]  R. McLeod,et al.  Nutritional status and function in patients following Whipple procedure compared with controls. , 1996, Journal of the American College of Nutrition.

[51]  Hill Gl,et al.  Long-term changes in body composition after pancreatoduodenectomy. , 1991 .

[52]  Jeffrey E. Lee,et al.  Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience , 2016, Journal of Gastrointestinal Surgery.

[53]  R. Wolff,et al.  Does IGFR 1 inhibition result in increased muscle mass loss in patients undergoing treatment for pancreatic cancer ? , 2014 .

[54]  J. Baeyens,et al.  European working group on sarcopenia in older people. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people , 2010 .

[55]  G. Hill,et al.  Long-term changes in body composition after pancreatoduodenectomy. , 1991, Journal of the Royal College of Surgeons of Edinburgh.